Kolexia
Chancerelle De Roquancourt Anne Anatomie et cytologie
Chancerelle De Roquancourt Anne
Anatomie et cytologie
Hôpital Saint-Louis
Paris, France
52 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du sein triple-négatives Carcinomes Récidive tumorale locale Carcinome canalaire Métastase tumorale Cancers du sein inflammatoires Épithélioma in situ Carcinome intracanalaire non infiltrant

Collaborateurs

Voir plus
Espie Marc
Espie Marc
Hôpital Saint-Louis, Paris, France
Giacchetti Sylvie
Giacchetti Sylvie
Hôpital Saint-Louis, Paris, France
Cuvier Caroline
Cuvier Caroline
Hôpital Saint-Louis, Paris, France
Groheux David
Groheux David
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
MSD
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.
Cancers   04 mars 2022
Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.
Cancers   17 septembre 2020
Outcome of triple negative inflammatory breast cancers (TNIBC) treated with dose dense neoadjuvant epirubicin cyclophosphmide, prognostic impact of pre and post neoadjuvant chemotherapy (NAC) tumour infiltrating lymphocytes (TIL) and post NAC lymphovascular invasion
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
A misleading breast metastasis of medullary thyroid carcinoma.
Annales de pathologie   12 décembre 2018
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.
Oncotarget   09 mars 2018
La mastectomie de trop ? - Grand Prix 2016 : 1er lauréat
Edimark   31 mars 2016
Abstract P1-14-08: Prediction of pathological response (pCR) to neoadjuvant dose dense and intense cyclophosphamide and anthracycline in a prospective series of triple negative locally advanced breast cancers (TNLABC)
Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium   15 février 2016
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   23 décembre 2015
Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
Breast (Edinburgh, Scotland)   10 novembre 2015
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
European journal of nuclear medicine and molecular imaging   04 juillet 2015